Literature DB >> 20477917

Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant.

K Weller, M Magerl, M Maurer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20477917     DOI： 10.1111/j.1468-3083.2010.03712.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  6 in total

Review 1.  [Angioedema prophylaxis].

Authors:  V Zampeli; M Magerl
Journal:  Hautarzt       Date:  2019-02       Impact factor: 0.751

2.  Acquired C1-inhibitor deficiency: 7 patients treated with rituximab.

Authors:  Albanne Branellec; Laurence Bouillet; Nicolas Javaud; Arsène Mekinian; Isabelle Boccon-Gibod; Claire Blanchard-Delaunay; Eric Oksenhendler; Yann Ollivier; Bertrand Dunogué; Stephanie Amarger; Denise Ponard; Christian Drouet; Luc Mouthon; Michel Thomas; Olivier Fain
Journal:  J Clin Immunol       Date:  2012-04-20       Impact factor: 8.317

3.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.

Authors:  Tom Bowen; Marco Cicardi; Henriette Farkas; Konrad Bork; Hilary J Longhurst; Bruce Zuraw; Emel Aygoeren-Pürsün; Timothy Craig; Karen Binkley; Jacques Hebert; Bruce Ritchie; Laurence Bouillet; Stephen Betschel; Della Cogar; John Dean; Ramachand Devaraj; Azza Hamed; Palinder Kamra; Paul K Keith; Gina Lacuesta; Eric Leith; Harriet Lyons; Sean Mace; Barbara Mako; Doris Neurath; Man-Chiu Poon; Georges-Etienne Rivard; Robert Schellenberg; Dereth Rowan; Anne Rowe; Donald Stark; Smeeksha Sur; Ellie Tsai; Richard Warrington; Susan Waserman; Rohan Ameratunga; Jonathan Bernstein; Janne Björkander; Kristylea Brosz; John Brosz; Anette Bygum; Teresa Caballero; Mike Frank; George Fust; George Harmat; Amin Kanani; Wolfhart Kreuz; Marcel Levi; Henry Li; Inmaculada Martinez-Saguer; Dumitru Moldovan; Istvan Nagy; Erik W Nielsen; Patrik Nordenfelt; Avner Reshef; Eva Rusicke; Sarah Smith-Foltz; Peter Späth; Lilian Varga; Zhi Yu Xiang
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

4.  An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.

Authors:  Bernard Floccard; Etienne Hautin; Laurence Bouillet; Brigitte Coppere; Bernard Allaouchiche
Journal:  Core Evid       Date:  2012-09-27

5.  In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency.

Authors:  A L Manson; A Price; J Dempster; P Clinton-Tarestad; C Greening; R Enti; S Hill; S Grigoriadou; M S Buckland; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

6.  Hereditary angioedema: epidemiology, management, and role of icatibant.

Authors:  Aasia Ghazi; J Andrew Grant
Journal:  Biologics       Date:  2013-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.